Table 3.
CMR | Pathophysiologic Background | Clinical Setting | Information |
---|---|---|---|
LGE | Fibrosis | ICM, NICM HCM, Myocarditis ARVC, LVNC Mitral valve prolapse |
Independent predictor for VA and SCD |
T1 and ECV | Tissue edema and diffuse fibrosis | ICM, NICM HCM, Myocarditis |
Higher native T1 values associated with VA |
T2 | Myocardial edema | Myocarditis | Abnormal T2 mapping is involved in predicting major adverse events including cardiac death |
LVEF | Left ventricular systolic function | ICM, NICM Myocarditis, ARVC LVNC |
LV systolic dysfunction is associated with an increased risk of SCD |
RVEF | Right ventricular systolic function | ARVDC | Overall increase in VA in RV dysfunction |
Strain Imaging and MD | Myocardial deformation and function | ICM, NICM | Impaired strain associated with SCD |
CMR: cardiac magnetic resonance; LGE: late Gadolinium enhancement; ICM: ischemic cardiomyopathy; NICM: non-ischemic cardiomyopathy; HCM: hypertrophic cardiomyopathy; ARVC: arrhythmogenic right ventricular cardiomyopathy; LVNC: left ventricular noncompaction; RVEF: right ventricular ejection fraction.